Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Osteoarthritis (OA) of the hip is a frequent and debilitating joint disease. Only few clinical risk factors for hip OA are established and clinically applicable biomarkers to identify patients at risk are still lacking. The glycoprotein vascular cell adhesion molecule 1 (VCAM-1) is expressed by chondrocytes and synovial tissue and was a predictive marker for development of severe large joint OA in a previous study.
It was tested whether increased serum levels of VCAM-1 are prevalent in patients with severe OA of the hips.
In this prospective, multicenter, cross-sectional study, risk factors of severe hip OA were investigated in patients scheduled for hip joint arthroplasty and 100 patients were randomly selected for validation of VCAM-1 as a potential biomarker for hip OA. Serum samples were analyzed by an enzyme-linked immunosorbent assay and compared with a sex and age-matched control cohort.
The groups were similar in age, gender ratio and prevalence of diabetes. Serum concentrations of VCAM-1 were 8% higher in OA patients compared to controls, without reaching statistical significance (818 ng ml−1, 95% confidence interval, CI 746–891 ng ml−1 versus 759 ng m−1, 95% CI 711–807 ng ml−1; P = 0.4839).
The results of this study show that serum concentrations of VCAM-1 cannot distinguish patients with severe hip OA from age and sex-matched controls.
Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59(6):1203–11. CrossRef
Kienzle G, von Kempis J. Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. Arthritis Rheum. 1998;41(7):1296–305. CrossRefPubMed
Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol. 1992;149(4):1424–31. PubMed
Hoeven TA, Kavousi M, Ikram MA, van Meurs JB, Bindels PJ, Hofman A, et al. Markers of atherosclerosis in relation to presence and progression of knee osteoarthritis: a population-based cohort study. Rheumatology (Oxford). 2015;54(9):1692–8. CrossRef
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42. CrossRef
Pulsatelli L, Assirelli E, Dolzani P, Addimanda O, Mancarella L, Pavloska B, et al. Increased serum vascular cell adhesion molecule (VCAM)-1 levels in patients with erosive hand osteoarthritis. Rheumatology (Oxford). 2013;52(2):400–2. CrossRef
Kalichman L, Pantsulaia I, Kobyliansky E. Association between vascular cell adhesion molecule 1 and radiographic hand osteoarthritis. Clin Exp Rheumatol. 2011;29(3):544–6. PubMed
Tseng YH, Chiou SS, Zeng YS, Tsai SP, Chen CS, Liao YM, et al. Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy. Medicine (Baltimore). 2016;95(46):e5384. CrossRef
Ford I, Norrie J. Pragmatic trials. N Engl J Med. 2016;375(5):454–63. CrossRef
Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E‑selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96(12):4219–25. CrossRef
Miller MA, Cappuccio FP. Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population. Int J Obes (Lond). 2006;30(8):1176–82. CrossRef
Vascular cell adhesion molecule 1 in patients with severe osteoarthritis of the hip
A prospective cross-sectional study
- Springer Vienna
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II